Literature DB >> 27464805

Zebrafish as a Model for the Study of Solid Malignancies.

Genevieve C Kendall1,2, James F Amatruda3,4,5.   

Abstract

Zebrafish cancer models have provided critical insight into understanding the link between aberrant developmental pathways and tumorigenesis. The unique strengths of zebrafish as compared to other vertebrate model systems include the combination of fecundity, readily available and efficient transgenesis techniques, transparency that facilitates in vivo cell lineage tracing, and amenability for high-throughput applications. In addition to early embryo readouts, zebrafish can develop tumors at ages ranging from 2 weeks old to adulthood. Tumorigenesis is driven by genetically introducing oncogenes using selected promoter/tissue-specific expression, with either mosaic expression or with the generation of a stable transgenic line. Here, we detail a research pipeline to facilitate the study of human oncogenes in zebrafish systems. The goals of this approach are to identify conserved developmental pathways that may be critical for tumor development and to create platforms for testing novel therapies.

Entities:  

Keywords:  Functional genomics; Gateway cloning; Histopathology; Solid malignancies; Tol2; Transgenesis; Zebrafish tumor model

Mesh:

Year:  2016        PMID: 27464805     DOI: 10.1007/978-1-4939-3771-4_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis.

Authors:  Genevieve C Kendall; Sarah Watson; Lin Xu; Collette A LaVigne; Whitney Murchison; Dinesh Rakheja; Stephen X Skapek; Franck Tirode; Olivier Delattre; James F Amatruda
Journal:  Elife       Date:  2018-06-05       Impact factor: 8.140

2.  Dysregulated heparan sulfate proteoglycan metabolism promotes Ewing sarcoma tumor growth.

Authors:  Elena Vasileva; Mikako Warren; Timothy J Triche; James F Amatruda
Journal:  Elife       Date:  2022-03-14       Impact factor: 8.140

3.  Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer.

Authors:  Yanting You; Qiuxing He; Hanqi Lu; Xinghong Zhou; Liqian Chen; Huaxi Liu; Zibin Lu; Dongyi Liu; Yanyan Liu; Daming Zuo; Xiuqiong Fu; Hiuyee Kwan; Xiaoshan Zhao
Journal:  Front Pharmacol       Date:  2020-03-12       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.